Skip to main content

Table 4 Details of studies included in systematic review and meta-analysis

From: Myocardial injury in hospitalized COVID-19 patients: a retrospective study, systematic review, and meta-analysis

References, study design

State, health system, number of hospitals

Total number of patients

Myocardial Injury N (%)

No myocardial injury N (%)

Troponin assay used

Patient population

Main finding

Lala et al. [10], Retrospective

New York, Mount Sinai Health System, 5

2736

985 (36)

1751 (64)

Cardiac troponin I (Abbott Architect)

Hospitalized

COVID-19 patients with CVD were more likely to have myocardial injury than patients without CVD. Troponin elevation among patients hospitalized with COVID-19 was associated with higher risk of mortality

Majure et al. [11]

Retrospective

New York,

Northwell Health System

13

6247

1821 (29)

4426 (71)

cardiac troponin I (Siemens Dimension Vista; Siemens Dimension EXL Systems); cardiac troponin T (Roche Troponin T STAT, 4th generation; Elecys Troponin T Gen 5 STAT)

Hospitalized

Patients hospitalized with COVID-19 and elevated troponin had increased mortality compared with patients with normal troponin levels, which was independent of cardiovascular co-morbidities and elevated inflammatory markers

Case et al. [12]

Retrospective

Maryland (& Washington D.C.)

MedStar Health System

11

2716

250 (9.2)

2466 (90.8)

Troponin I

Hospitalized

COVID-19 patients with troponin elevation were at higher risk for mechanical ventilation and in-hospital mortality

De Michieli et al. [13]

Retrospective

Minnesota, Wisconsin, Florida, Arizona

Mayo Clinic Health System

17

367

169 (46)

198 (54)

Hs-cardiac troponin T (Elecys Troponin T Gen 5 STAT)

Hospitalized

Myocardial injury is prognostic in COVID-19 patients with regard to short-term mortality and major adverse events. A single hs-cTnT < 6 ng/L at presentation was associated with a more favorable prognosis

Pachtman Shetty et al. [14]

Retrospective

New York

Northwell Health

7

18

4 (22)

14 (78)

Hs-Trop, Troponin T, Troponin I

Pregnant and immediately postpartum hospitalized for COVID-19

Among pregnant women hospitalized for COVID-19, 20% were found to have elevations in troponin and 30% had elevated BNP

Metkus et al. [9]

Retrospective

Maryland,

Johns Hopkins Health System

5

243

124 (51)

119 (49)

Troponin T or Troponin I

COVID-19 patients who required intubation

Myocardial injury in patients with severe COVID-19 was a function of comorbidities, age, and multisystem organ dysfunction

Myocardial injury was associated with > twofold hazard for death

Changal (2021)

Retrospective*

Ohio,

Promedica Health System

2

258

58 (22.5)

210 (77.5)

Troponin I (Sunquest)

Hospitalized COVID-19 patients

Myocardial injury was common, and predicted mortality, poor outcomes, and discharge to skilled nursing facility

  1. *Our study as detailed in this manuscript
  2. CVD cardiovascular disease, hs-cTnT high sensitivity cardiac troponin-t, BNP brain natriuretic peptide